Overview

Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma

Status:
Completed

Trial end date:
2015-05-22

Target enrollment:

Participant gender:

Summary

This randomized phase III trial is comparing how well fludarabine and cyclophosphamide work when given together with or without rituximab in treating patients with previously untreated mantle cell lymphoma.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Derriford Hospital
University College, London

Collaborator:

Cancer Research UK

Treatments:

Cyclophosphamide
Fludarabine
Fludarabine phosphate
Rituximab
Vidarabine